CTRC, AACR and Baylor College of Medicine to host San Antonio Breast Cancer Symposium

What:

Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium remains the top venue for research and discovery in breast cancer. This year's conference will bring together delegates from all over the world. Among the expected highlights:

• Five-year results of the groundbreaking Herceptin trial.
  
• Definitive data on the role of bisphosphonates in breast cancer prevention.
  
• The role hormone therapies may play in lung cancer treatment.
  
• New data on the role of obesity and alcohol in breast cancer risk.
  
• Emerging therapies that could change the treatment landscape.

To help you plan your coverage of the conference, the program schedule is available online at http://www.sabcs.org. Although the full abstracts will not be available online until the conference begins, an electronic press kit containing the press releases and select highlighted abstracts will be available on Dec. 2, 2009 to reporters registered through the AACR and those with a subscription to Eurekalert and/or Newswise.

More than 2,000 abstracts will be presented for the first time at the conference, complementing an outstanding program of scientific and educational events. The CTRC-AACR San Antonio Breast Cancer Symposium attracts world leaders in cancer research and treatment, including clinical oncologists, industry leaders, basic scientists and translational researchers who are working to improve patient care with the ultimate goal of eradicating breast cancer.

When:
Dec. 9-13, 2009

Where:

Henry B. Gonzales Convention Center

San Antonio, Texas

Source: American Association for Cancer Research